Skip to content

Ketamine for anxiety: all studies

Page 9 of 19: studies 81 to 90 of 187, newest first. Back to the ketamine for anxiety overview

Research

The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats.

Psychopharmacology July 1, 2024 Dilan Gokalp, Gunes Unal

Ketamine produces dissociative, psychomimetic, anxiolytic, antidepressant, and anesthetic effects in a dose dependent manner. It has a complex mechanism of action that involve alterations in other glutamate receptors. The metabotropic glutamate receptor 5 (mGluR5) has been investigated in relation to the psychotic and anesthetic properties of ketamine, while its role in mediating the...

Ketamine-Assisted Psychotherapy Provides Lasting and Effective Results in the Treatment of Depression, Anxiety, and Post-Traumatic Stress Disorder at 3 and 6 Months: Findings from a Large Retrospective Effectiveness Study.

Psychedelic medicine (New Rochelle, N.Y.) June 1, 2024 Ryan Yermus, John Bottos, Nathan Bryson et al. 13 citations

Ketamine-assisted psychotherapy (KAP) is an emerging treatment option to alleviate treatment-resistant affective disorders, but its long-term effectiveness remains unclear. To examine the treatment effects of KAP on anxiety, depression, and post-traumatic stress disorder (PTSD) at 1, 3, and 6 months post-treatment. This retrospective effectiveness study included self-reported outcomes from...

Effects of ketamine on the severity of depression and anxiety following postoperative mechanical ventilation: a single-blind randomized clinical trial in Iran.

Acute and critical care May 1, 2024 Seyedbabak Mojaveraghili, Fatemeh Talebi, Sima Ghorbanoghli et al. 1 citation

In this study, we compare the effects of ketamine and the combination of midazolam and morphine on the severity of depression and anxiety in mechanically ventilated patients after discharge from the intensive care unit (ICU). This randomized single-blind clinical trial included 50 patients who were candidates for craniotomy and postoperative mechanical ventilation in the ICU of 5 Azar Teaching...

The Effect of Preprocedural Low-Dose Ketamine for Pain and Anxiety in Patients during Thoracic Epidural Catheterization.

Medicina (Kaunas, Lithuania) April 22, 2024 Onur Küçük, Esra Sarı, Musa Zengin et al. 2 citations

Background and Objectives: Thoracic epidural catheterization (TEC) can be both uncomfortable and fearful for patients when performed awake with the thought that the procedure may be painful. The aim of this study was to assess the effect of low-dose intravenous ketamine administration on pain and anxiety during the TEC procedure. Materials and Methods: Sixty patients were randomly divided into...

DOI: 10.3390/medicina60040679 (opens in new tab) Full text (opens in new tab) Ketamine Preprocedural low dose Thoracic epidural catheterization Pain management +4

The Effect of the Apollo Neuro Device on Anxiety Among Participants who Underwent Ketamine Assisted Therapy

European Psychiatry April 1, 2024 V. Tsang

IntroductionThe study aimed to evaluate the effectiveness of a device called “Apollo” in reducing anxiety, as compared to a control group. Participants were divided into two groups: the intervention group (receiving the “Apollo” device) and the control group (receiving no intervention).ObjectivesThe primary outcome measure was the change in Generalized Anxiety Disorder 7-item (GAD-7) scores,...

Sublingual Ketamine for Depression and Anxiety: A Retrospective Study of Real-World Clinical Outcomes

medRxiv Preprint Server January 30, 2024 Lauren N. Swanson, Lila S. Jones, Jose Muñoz Aycart et al. preprint

Objective To evaluate the effectiveness of repeated at-home ketamine treatments for depression, generalized anxiety, and social anxiety and assess safety in terms of adverse effects and tendency towards long-term use.

DOI: 10.1101/2024.01.30.24301798 (opens in new tab) Full text (opens in new tab) Mental health treatment Ketamine therapy Depression & anxiety Treatment efficacy +1

Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxiety

Frontiers in Psychiatry January 23, 2024 Johannes Hauser, Jan Sarlon, Timur Liwinski et al. 10 citations

BackgroundAlthough the effectiveness of (es)ketamine for therapy-resistant depression (TRD) has been established, potential treatment-limiting factors include side effects like dissociation, anxiety, or elevated blood pressure. Music can reduce stress and negative emotions as anxiety. This study aimed to investigate the impact of listening to music during intranasal (es)ketamine administration...

Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression

Journal of Child and Adolescent Psychopharmacology January 3, 2024 Alice Lineham, Victor J. Avila‐quintero, Michael H. Bloch et al. 15 citations

Objective:Ketamine has proved effective as a rapid-acting antidepressant agent, but treatment is not effective for everyone (approximately a quarter to a half of patients). Some adult studies have begun to investigate predictors of ketamine's antidepressant response, but no studies have examined this in adolescents with depression. Methods:We conducted a secondary data analysis of adolescents...

Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants.

Journal of Psychoactive Drugs 2024 Reid Robison, Madeline Brendle, Claire Moore et al.

This study reports on 10 frontline healthcare workers, employed during the COVID-19 pandemic and experiencing symptoms of burnout and PTSD, treated with group ketamine-assisted psychotherapy (KAP) in a private outpatient clinic setting. Participants attended 6 sessions once weekly. These included 1 preparation session, 3 ketamine sessions (2 sublingual, 1 intramuscular), 2 integration sessions....

Mechanisms of SSRI Therapy and Discontinuation.

Current Topics in Behavioral Neurosciences 2024 Trevor Sharp, Helen M Collins 40 citations

SSRIs are one of the most widely used drug therapies in primary care and psychiatry, and central to the management of the most common mental health problems in today's society. Despite this, SSRIs suffer from a slow onset of therapeutic effect and relatively poor efficacy as well as adverse effects, with recent concerns being focused on a disabling SSRI discontinuation syndrome. The mechanism...